OBJECTIVES: Lactation may influence future progression to type 2 diabetes after gestational diabetes mellitus (GDM). However, biomarkers associated with progression to glucose intolerance have not been examined in relation to lactation intensity among postpartum women with previous GDM. This study investigates whether higher lactation intensity is related to more favorable blood lipids, lipoproteins and adipokines after GDM pregnancy independent of obesity, socio-demographics and insulin resistance. METHODS: The Study of Women, Infant Feeding, and Type 2 Diabetes (SWIFT) is a prospective cohort study that recruited 1035 women diagnosed with GDM by the 3-h 100g oral glucose tolerance tests (OGTTs) after delivery of a live birth in 2008-2011. Research staff conducted 2-h 75 g OGTTs, and assessed lactation intensity, anthropometry, lifestyle behaviors and socio-demographics at 6-9 weeks postpartum (baseline). We assayed fasting plasma lipids, lipoproteins, non-esterified free fatty acids, leptin and adiponectin from stored samples obtained at 6-9 weeks postpartum in 1007 of the SWIFT participants who were free of diabetes at baseline. Mean biomarker concentrations were compared among lactation intensity groups using multivariable linear regression models. RESULTS: Increasing lactation intensity showed graded monotonic associations with fully adjusted mean biomarkers: 5%-8% higher high-density lipoprotein cholesterol (HDL-cholesterol), 20%-28% lower fasting triglycerides, 15%-21% lower leptin (all trend P-values < 0.01), and with 6% lower adiponectin, but only after adjustment for insulin resistance (trend P-value = 0.04). CONCLUSION: Higher lactation intensity was associated with more favorable biomarkers for type 2 diabetes, except for lower plasma adiponectin, after GDM delivery. Long-term follow-up studies are needed to assess whether these effects of lactation persist to predict progression to glucose intolerance.
OBJECTIVES:Lactation may influence future progression to type 2 diabetes after gestational diabetes mellitus (GDM). However, biomarkers associated with progression to glucose intolerance have not been examined in relation to lactation intensity among postpartum women with previous GDM. This study investigates whether higher lactation intensity is related to more favorable blood lipids, lipoproteins and adipokines after GDM pregnancy independent of obesity, socio-demographics and insulin resistance. METHODS: The Study of Women, Infant Feeding, and Type 2 Diabetes (SWIFT) is a prospective cohort study that recruited 1035 women diagnosed with GDM by the 3-h 100g oral glucose tolerance tests (OGTTs) after delivery of a live birth in 2008-2011. Research staff conducted 2-h 75 g OGTTs, and assessed lactation intensity, anthropometry, lifestyle behaviors and socio-demographics at 6-9 weeks postpartum (baseline). We assayed fasting plasma lipids, lipoproteins, non-esterified free fatty acids, leptin and adiponectin from stored samples obtained at 6-9 weeks postpartum in 1007 of the SWIFT participants who were free of diabetes at baseline. Mean biomarker concentrations were compared among lactation intensity groups using multivariable linear regression models. RESULTS: Increasing lactation intensity showed graded monotonic associations with fully adjusted mean biomarkers: 5%-8% higher high-density lipoprotein cholesterol (HDL-cholesterol), 20%-28% lower fasting triglycerides, 15%-21% lower leptin (all trend P-values < 0.01), and with 6% lower adiponectin, but only after adjustment for insulin resistance (trend P-value = 0.04). CONCLUSION: Higher lactation intensity was associated with more favorable biomarkers for type 2 diabetes, except for lower plasma adiponectin, after GDM delivery. Long-term follow-up studies are needed to assess whether these effects of lactation persist to predict progression to glucose intolerance.
Authors: Alison M Stuebe; Ken Kleinman; Matthew W Gillman; Sheryl L Rifas-Shiman; Erica P Gunderson; Janet Rich-Edwards Journal: J Womens Health (Larchmt) Date: 2010-05 Impact factor: 2.681
Authors: Marie-France Hivert; Qi Sun; Peter Shrader; Christol S Mantzoros; James B Meigs; Frank B Hu Journal: Obesity (Silver Spring) Date: 2010-09-02 Impact factor: 5.002
Authors: R Retnakaran; A J G Hanley; N Raif; C R Hirning; P W Connelly; M Sermer; S E Kahn; B Zinman Journal: Diabetologia Date: 2005-03-19 Impact factor: 10.122
Authors: Nira Ben-Jonathan; Eric R Hugo; Terry D Brandebourg; Christopher R LaPensee Journal: Trends Endocrinol Metab Date: 2006-03-06 Impact factor: 12.015
Authors: Alison M Stuebe; Christos Mantzoros; Ken Kleinman; Matthew W Gillman; Sheryl Rifas-Shiman; Erica P Gunderson; Janet Rich-Edwards Journal: Diabetes Date: 2011-02-24 Impact factor: 9.461
Authors: Ziyi Zhang; Anthony L Piro; Amina Allalou; Stacey E Alexeeff; Feihan F Dai; Erica P Gunderson; Michael B Wheeler Journal: J Clin Endocrinol Metab Date: 2022-08-18 Impact factor: 6.134
Authors: Erica P Gunderson; Shanta R Hurston; Xian Ning; Joan C Lo; Yvonne Crites; David Walton; Kathryn G Dewey; Robert A Azevedo; Stephen Young; Gary Fox; Cathie C Elmasian; Nora Salvador; Michael Lum; Barbara Sternfeld; Charles P Quesenberry Journal: Ann Intern Med Date: 2015-11-24 Impact factor: 25.391
Authors: Maria Inês Schmidt; Bruce B Duncan; Cristina Castilhos; Eliana Márcia Wendland; Pedro C Hallal; Beatriz D'Agord Schaan; Michele Drehmer; Adriana Costa E Forti; Cristina Façanha; Maria Angélica Nunes Journal: BMC Pregnancy Childbirth Date: 2016-03-30 Impact factor: 3.007
Authors: Mi Lai; Dana Al Rijjal; Hannes L Röst; Feihan F Dai; Erica P Gunderson; Michael B Wheeler Journal: Elife Date: 2020-08-04 Impact factor: 8.140